These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38106428)

  • 1. Disparate viral pandemics from COVID19 to monkeypox and beyond: a simple, effective and universal therapeutic approach hiding in plain sight.
    Johnson HM; Ahmed CM
    Front Immunol; 2023; 14():1208828. PubMed ID: 38106428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19.
    Johnson HM; Lewin AS; Ahmed CM
    Front Immunol; 2020; 11():582102. PubMed ID: 33193390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual and Synergistic Anti-Coronavirus Activities of SOCS1/3 Antagonist and Interferon α1 Peptides.
    Ahmed CM; Grams TR; Bloom DC; Johnson HM; Lewin AS
    Front Immunol; 2022; 13():902956. PubMed ID: 35799776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 main protease inhibitors: What is moving in the field of peptides and peptidomimetics?
    Algar-Lizana S; Bonache MÁ; González-Muñiz R
    J Pept Sci; 2023 May; 29(5):e3467. PubMed ID: 36479966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?
    Hashemian SMR; Sheida A; Taghizadieh M; Memar MY; Hamblin MR; Bannazadeh Baghi H; Sadri Nahand J; Asemi Z; Mirzaei H
    Biomed Pharmacother; 2023 Jun; 162():114367. PubMed ID: 37018987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling.
    Ahmed CM; Dabelic R; Martin JP; Jager LD; Haider SM; Johnson HM
    J Immunol; 2010 Jul; 185(2):1103-13. PubMed ID: 20543109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 Are Stimulated within the Eye during Experimental Murine Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression.
    Chien H; Alston CI; Dix RD
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Coronavirus Transmissible Gastroenteritis Virus Evades the Type I Interferon Response through IRE1α-Mediated Manipulation of the MicroRNA miR-30a-5p/SOCS1/3 Axis.
    Ma Y; Wang C; Xue M; Fu F; Zhang X; Li L; Yin L; Xu W; Feng L; Liu P
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory Syncytial Virus Nonstructural Proteins Upregulate SOCS1 and SOCS3 in the Different Manner from Endogenous IFN Signaling.
    Zheng J; Yang P; Tang Y; Pan Z; Zhao D
    J Immunol Res; 2015; 2015():738547. PubMed ID: 26557722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.
    Piganis RA; De Weerd NA; Gould JA; Schindler CW; Mansell A; Nicholson SE; Hertzog PJ
    J Biol Chem; 2011 Sep; 286(39):33811-8. PubMed ID: 21757742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Suppressor of Cytokine Signalling family of proteins and their potential impact on COVID-19 disease progression.
    Low ZY; Wen Yip AJ; Chow VTK; Lal SK
    Rev Med Virol; 2022 May; 32(3):e2300. PubMed ID: 34546610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.
    Song MM; Shuai K
    J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).
    Olière S; Hernandez E; Lézin A; Arguello M; Douville R; Nguyen TL; Olindo S; Panelatti G; Kazanji M; Wilkinson P; Sékaly RP; Césaire R; Hiscott J
    PLoS Pathog; 2010 Nov; 6(11):e1001177. PubMed ID: 21079688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
    Metz-Zumaran C; Kee C; Doldan P; Guo C; Stanifer ML; Boulant S
    J Virol; 2022 Apr; 96(7):e0170521. PubMed ID: 35262371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system.
    Ahmed CM; Dabelic R; Waiboci LW; Jager LD; Heron LL; Johnson HM
    J Virol; 2009 Feb; 83(3):1402-15. PubMed ID: 19019946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
    Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
    Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-silico guided design, screening, and molecular dynamic simulation studies for the identification of potential SARS-CoV-2 main protease inhibitors for the targeted treatment of COVID-19.
    Gutti G; He Y; Coldren WH; Lalisse RF; Border SE; Hadad CM; McElroy CA; Ekici ÖD
    J Biomol Struct Dyn; 2024; 42(4):1733-1750. PubMed ID: 37114441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.